0001209191-22-062662.txt : 20221223 0001209191-22-062662.hdr.sgml : 20221223 20221223173217 ACCESSION NUMBER: 0001209191-22-062662 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221222 FILED AS OF DATE: 20221223 DATE AS OF CHANGE: 20221223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zelen Matt CENTRAL INDEX KEY: 0001887917 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41049 FILM NUMBER: 221486230 MAIL ADDRESS: STREET 1: C/O USERTESTING, INC. STREET 2: 144 TOWNSEND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UserTesting, Inc. CENTRAL INDEX KEY: 0001557127 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372] IRS NUMBER: 260339214 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 144 TOWNSEND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: (650) 567-5616 MAIL ADDRESS: STREET 1: 144 TOWNSEND STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94107 FORMER COMPANY: FORMER CONFORMED NAME: User Testing, Inc. DATE OF NAME CHANGE: 20120828 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-12-22 0 0001557127 UserTesting, Inc. USER 0001887917 Zelen Matt 144 TOWNSEND STREET SAN FRANCISCO CA 94107 0 1 0 0 Chief Operating Officer Common Stock 2022-12-22 4 M 0 13750 1.06 A 39932 D Common Stock 2022-12-22 4 S 0 19046 7.5007 D 20886 D Employee Stock Option (Right to Buy) 1.06 2022-12-22 4 M 0 13750 0.00 D 2029-12-23 Common Stock 13750 708750 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.505 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option vested as to 1/4th of the total shares December 2, 2020 and then 1/48th of the total shares vest monthly thereafter, subject to the Reporting Holder's continued service to the Issuer on each vesting date. /s/ Mona Sabet as attorney-in-fact for Matt Zelen 2022-12-23